Nov 01, 2023
256:249
For every 249 shares held, investors received 256. The price per share adjusted from $0.61 to $0.60.
The split itself did not change the total investment value.
Paradigm Biopharmaceuticals Ltd. (ASX:PAR) operates in the Pharmaceuticals: generic industry.
Paradigm Biopharmaceuticals Ltd. company overviewParadigm Biopharmaceuticals Ltd.'s most recent stock split was on November 1, 2023. It was a 256-for-249 forward split, so shareholders received 256 shares for every 249 they held.
Paradigm Biopharmaceuticals Ltd. (ASX:PAR) has split its stock 3 times: a 171-for-167 split on April 17, 2019, a 415-for-412 split on August 17, 2022, and a 256-for-249 split on November 1, 2023.
Paradigm Biopharmaceuticals Ltd. has split its stock 3 times. This history records 3 forward splits between April 17, 2019 and November 1, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Paradigm Biopharmaceuticals Ltd.'s 256-for-249 split on November 1, 2023, every 249 shares became 256 shares.
Paradigm Biopharmaceuticals Ltd. has not announced a new split in our records. Its most recent split was on November 1, 2023, 2 years ago. Companies announce splits in advance, and any new ASX:PAR split will appear on this page.
Already premium?